Australians can access the first GLP-1 pills for weight loss through private prescription from Friday, likely boosting sales of the popular drugs already used by more than half a million people here.
Glucagon-like peptide-1 receptor agonists, or GLP-1s, were previously only available through a weekly injection, while the new Wegovy and Foundayo pills are taken as daily oral tablets.
Millions of Australians are expected to use GLP-1s in the coming years, with the drugs boasting powerful health effects including significant weight loss, improved blood glucose control and other metabolic health benefits.
However, experts have warned there is a…
Read the full article at SMH.COM.AU












